Why the study?
To highlight the most important studies published in the European Heart Journal—Cardiovascular Imaging during 2020 focusing on valvular heart disease, heart failure, cardiomyopathies, and congenital heart disease.
Key points are not available for this paper at this time.
Design
Review
Positions the European Heart Journal—Cardiovascular Imaging as Europe's top imaging journal; leaves open the clinical translation of its 2020 study highlights.
The European Heart Journal—Cardiovascular Imaging was launched in 2012 and has during these years become one of the leading multimodality cardiovascular imaging journal. The journal is now established as one of the top cardiovascular journals and is the most important cardiovascular imaging journal in Europe. The most important studies published in our Journal from 2020 will be highlighted in two reports. Part II will focus on valvular heart disease, heart failure, cardiomyopathies, and congenital heart disease. While Part I of the review has focused on studies about myocardial function and risk prediction, myocardial ischaemia, and emerging techniques in cardiovascular imaging.
No takes yet. Share an insight, caveat, or question.
Cosyns et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: